(Q48089043)

8 February 2018

title

Migraine polypharmacy and the tolerability of sumatriptan: a large-scale, prospective study (English)

1 reference

8 February 2018

1 reference

G P Putnam

1

1 reference

8 February 2018

S O'Quinn

2

1 reference

8 February 2018

C P Bolden-Watson

3

1 reference

8 February 2018

R L Davis

4

1 reference

8 February 2018

D L Gutterman

5

1 reference

8 February 2018

A W Fox

6

1 reference

8 February 2018

language of work or name

English

0 references

publication date

1 September 1999

1 reference

8 February 2018

published in

Cephalalgia

1 reference

8 February 2018

volume

19

1 reference

8 February 2018

issue

7

1 reference

8 February 2018

page(s)

668-675

1 reference

8 February 2018

Migraine headache in a prepaid health plan: ascertainment, demographics, physiological, and behavioral factors.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019007668.X

Sumatriptan injection is superior to placebo in the acute treatment of migraine--with regard to both efficacy and general well-being

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019007668.X

Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019007668.X

Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019007668.X

Beyond monotherapy: rational polytherapy in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019007668.X

Headache and analgesic use in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019007668.X

Opioids in headache treatment. Is there a role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019007668.X

Clinical studies of valproate for migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019007668.X

Monoamine oxidase inhibitors and narcotic analgesics. A critical review of the implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019007668.X

Amitriptyline in Migraine Prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019007668.X

Double-blind trial of fluoxetine: chronic daily headache and migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019007668.X

Migraine prophylactic drugs: proof of efficacy, utilization and cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019007668.X

A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019007668.X

Joint 1994 Wolff Award Presentation. Migraine and major depression: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019007668.X

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019007668.X

Oral sumatriptan in acute migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019007668.X

10.1046/J.1468-2982.1999.019007668.X

21 January 2018

Identifiers

DOI

1 reference

8 February 2018

release_6fjddw46izhmvaxmggkef32f4i

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6fjddw46izhmvaxmggkef32f4i

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

8 February 2018